Skip to main content

ChemAxon establishes subsidiary in Basel

| News

ChemAxon establishes subsidiary in Basel


ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in Basel. The customer base and economic conditions were cited as reasons for the choice of location.

The Hungarian company ChemAxon has established the ChemAxon GmbH subsidiary in Basel. The software company chose Basel on account of the connection to customers in the chemicals and biopharma industries as well as the economic conditions. In setting up the new location, it was supported by Basel Area Business & Innovation, the investment and innovation promotion agency (read more about starting a business in Switzerland).

“During the evaluation process and after the incorporation period I was really impressed with all the support and help ChemAxon and I received from BaselArea Business & Innovation,” explains Annamaria Kovacs, the Basel-based representative of ChemAxon.

With headquarters in Budapest, ChemAxon also has offices in the USA, Prague and Asia. Worldwide, ChemAxon has 150 employees. The company’s software products help to accelerate and enhance scientific discovery and collaboration. The solutions are tailored to the requirements of customers in the chemicals and biopharma sectors.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.